Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Deficit)

v3.23.3
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance as of beginning of period (in shares) at Dec. 31, 2021   183,232,494      
Balance as of beginning of period at Dec. 31, 2021 $ 110,415,000 $ 2,000 $ 340,294,000 $ (14,000) $ (229,867,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 2,795,000 2,795,000      
Stock Issued During Period, Value, Stock Options Exercised $ 1,243,000   1,243,000    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 15,090,000 $ 385,324 15,090,000    
Issuance of common stock warrants in connection with financing (170,000)   (170,000)    
Net loss (12,587,000)       (12,587,000)
Other comprehensive income (1,121,000)     (1,121,000)  
Balance as of end of period (in shares) at Sep. 30, 2022   186,412,818      
Balance as of end of period at Sep. 30, 2022 112,870,000 $ 2,000 356,457,000 (1,135,000) (242,454,000)
Balance as of beginning of period (in shares) at Jun. 30, 2022   184,909,608      
Balance as of beginning of period at Jun. 30, 2022 182,583,000 $ 2,000 350,797,000 (957,000) (167,259,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,248,369      
Stock Issued During Period, Value, Stock Options Exercised 673,000   673,000    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 5,157,000 $ 254,841 5,157,000    
Issuance of common stock warrants in connection with financing (170,000)   (170,000)    
Net loss (75,195,000)       (75,195,000)
Other comprehensive income (178,000)     (178,000)  
Balance as of end of period (in shares) at Sep. 30, 2022   186,412,818      
Balance as of end of period at Sep. 30, 2022 112,870,000 $ 2,000 356,457,000 (1,135,000) (242,454,000)
Balance as of beginning of period (in shares) at Dec. 31, 2022   187,561,368      
Balance as of beginning of period at Dec. 31, 2022 $ 140,846,000 $ 2,000 361,528,000 (837,000) (219,847,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,400,000        
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   1,401,769      
Issuance of common stock upon exercise of stock options $ 410,000   410,000    
Shares Issued, Shares, Share-Based Payment Arrangement, Release of RSUs   3,119,282      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 19,486,000   19,486,000    
adjustments to Additional Paid in Capital, At-the-Market offering, net of issuance costs (18,423,000)   (18,423,000)    
Shares Issued, Shares, Share-Based Payment Arrangement, At-the-Market Offering, Net of Issuance Costs   8,232,565      
Net loss (76,795,000)       (76,795,000)
Other comprehensive income 585,000     585,000  
Balance as of end of period (in shares) at Sep. 30, 2023   200,314,984      
Balance as of end of period at Sep. 30, 2023 102,955,000 $ 2,000 399,847,000 (252,000) (296,642,000)
Balance as of beginning of period (in shares) at Jun. 30, 2023   196,737,320      
Balance as of beginning of period at Jun. 30, 2023 110,595,000 $ 2,000 390,240,000 (401,000) (279,246,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   106,334      
Issuance of common stock upon exercise of stock options 60,000   60,000    
Shares Issued, Shares, Share-Based Payment Arrangement, Release of RSUs   1,479,555      
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 6,716,000   6,716,000    
adjustments to Additional Paid in Capital, At-the-Market offering, net of issuance costs (2,831,000)   (2,831,000)    
Shares Issued, Shares, Share-Based Payment Arrangement, At-the-Market Offering, Net of Issuance Costs   1,991,775      
Net loss (17,396,000)       (17,396,000)
Other comprehensive income 149,000     149,000  
Balance as of end of period (in shares) at Sep. 30, 2023   200,314,984      
Balance as of end of period at Sep. 30, 2023 $ 102,955,000 $ 2,000 $ 399,847,000 $ (252,000) $ (296,642,000)